Your browser doesn't support javascript.
loading
Serotonin mediates the panicolytic-like effect of oxytocin in the dorsal periaqueductal gray.
De Oliveira Sergio, Thatiane; Frias, Alana Tercino; Vilela-Costa, Heloisa Helena; De Oliveira, Danielle Cg; Zuardi, Antônio W; Zangrossi, Hélio.
Afiliación
  • De Oliveira Sergio T; Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
  • Frias AT; Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
  • Vilela-Costa HH; Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
  • De Oliveira DC; Department of Neurosciences and Behavior, Division of Psychiatry, School of Medicine of Ribeirão Preto, University of São Paulo, Brazil.
  • Zuardi AW; Department of Neurosciences and Behavior, Division of Psychiatry, School of Medicine of Ribeirão Preto, University of São Paulo, Brazil.
  • Zangrossi H; Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
J Psychopharmacol ; 34(4): 383-390, 2020 04.
Article en En | MEDLINE | ID: mdl-32108540
INTRODUCTION AND OBJECTIVES: Oxytocin (OT) has been widely linked to positive social interactions, and there is great interest in OT as a therapy for a variety of neuropsychiatric conditions. Recent evidence also suggests that OT can play an important role in the mediation of anxiety-associated defensive responses, including a role for serotonin (5-HT) neurotransmission in this action. However, it is presently unknown whether OT additionally regulates the expression of panic-related behaviors, such as escape, by acting in the dorsal periaqueductal gray (dPAG), a key panic-regulating area. This study aimed to investigate the consequence of OT injection in the dPAG on escape expression and whether facilitation of 5-HT neurotransmission in this midbrain area is implicated in this action. METHODS: Male Wistar rats were injected with OT in the dPAG and tested for escape expression in the elevated T-maze (ETM) and dPAG electrical stimulation tests. Using the latter test, OT's effect was also investigated after previous intra-dPAG injection of the OT receptor antagonist atosiban, the preferential antagonists of 5-HT1A and 5-HT2A receptors, WAY-100635 and ketanserin, respectively, or systemic pretreatment with the 5-HT synthesis inhibitor p-CPA. RESULTS: OT impaired escape expression in the two tests used, suggesting a panicolytic-like effect. In the ETM, the peptide also facilitated inhibitory avoidance acquisition, indicating an anxiogenic effect. Previous administration of atosiban, WAY-100635, ketanserin, or p-CPA counteracted OT's anti-escape effect. CONCLUSIONS: OT and 5-HT in the dPAG interact in the regulation of panic- and anxiety-related defensive responses. These findings open new perspectives for the development of novel therapeutic strategies for the treatment of anxiety disorders.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pánico / Ansiolíticos / Oxitocina / Sustancia Gris Periacueductal / Serotonina Límite: Animals Idioma: En Revista: J Psychopharmacol Asunto de la revista: PSICOFARMACOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pánico / Ansiolíticos / Oxitocina / Sustancia Gris Periacueductal / Serotonina Límite: Animals Idioma: En Revista: J Psychopharmacol Asunto de la revista: PSICOFARMACOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Estados Unidos